EMA Seeks Comments on Rare Allergy Trials

Drug Industry Daily
A A
The European Medicines Agency is seeking public comments as it prepares new guidelines for rare allergy clinical trials.

To View This Article:

Login

Subscribe To Drug Industry Daily